Alexander Rabinovitch

InterCure Ltd. (NASDAQ:INCR) (TASE: INCR), an Israeli cannabis company doing business as Canndoc, announced its preliminary results on Monday for the full year of 2023. Preliminary H2 2023 Financial Highlights Revenue is estimated at NIS 140 million ($38.1 million). Adjusted EBITDA is estimated to...

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023, "The first half of 2023 is another solid performance for InterCure, with year-over-year revenue...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership. The partnership will see InterCure granted an exclusive distribution license to cultivate, manufacture, sell, market, and distribute all...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) released its financial results for the second quarter of 2022, revealing record revenue of approximately CA$37 million, more than double the revenues of the second quarter of 2021 and representing sequential growth of over 9%. Q2 2022 and...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) released preliminary financial results for the second quarter of 2022, revealing record revenue estimated to be CA$36 million ($27,86 million), more than double the revenues of the second quarter of 2021 and representing sequential growth of...

Parallel To Open Another Surterra Wellness Store In Florida Parallel is opening a second Surterra Wellness medical marijuana dispensary in Orlando. Located at 2820 East Colonial Drive, near the Milk District and alongside a variety of popular retail and dining options, the new store will hold a...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) opened the first flagship Cookies store in Austria, located in the Neubau district of Vienna. The flagship location offers Cookies' CBD menu, available for the first time in Europe, as well as clothing and life-style products. In the future...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) is opening its flagship Cookies pharmacy in Be'er Sheva, the largest city in Israel's southern region, known as the capital of the Negev. The pharmacy is located in the center of Be'er Sheva in front of city hall, in a building that...

InterCure (NASDAQ: INCR) released its financial results for the first quarter of 2022 and provided shareholders with a business update. All amounts are expressed in Canadian dollars or New Israeli Shekels (NIS) unless otherwise noted. First Quarter 2022 and Recent ...

InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, has announced its estimated financial and operating results for the fourth quarter and year ended December 31, 2021. Q4 Key Financial & Operating Highlights Record revenue of CA$33 million ($26.4...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) has signed a definitive agreement with Altman Health LP. The newly formed company will focus on the new Israeli CBD product market, following the Israeli Minister of Health's recent announcement that CBD will be removed from the Dangerous...

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR), doing business as Canndoc, announced record preliminary financial results for the fourth quarter of 2021. All amounts are expressed in Canadian dollars ($) or New Israeli Shekels (NIS), unless otherwise noted. Preliminary Fourth Quarter 2021...

Cannabis brand Cookies announced Thursday its international expansion into Europe through a partnership with Israel-based marijuana company InterCure (NASDAQ: INCR). The parties signed a multi-year deal under which InterCure will establish Cookies stores and medical cannabis pharmacies in Austria...

Israeli cannabis company InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which does business as Canndoc, released its third-quarter financial results Monday revealing all-time record quarterly revenue of CA$25 million ($19.97 million), three times greater than Q3 2020...